TherapeuticsMD, Inc. SEC filings TXMD
TherapeuticsMD, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 23, 2008. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Notification of late filing | Apr 1, 2026 | Dec 31, 2025 |
| AW | Amendment withdrawal request | Jun 14, 2024 | — |
| D | Filing | Jul 11, 2023 | — |
| NT 10-K | Filing | Mar 31, 2023 | Dec 31, 2022 |
| D | Filing | Nov 14, 2022 | — |
| D | Filing | Oct 17, 2022 | — |
| D | Filing | Aug 16, 2022 | — |
| SC 14D9/A | Filing | Jul 13, 2022 | — |
| SC TO-T/A | Filing | Jul 13, 2022 | — |
| SC 14D9/A | Filing | Jul 6, 2022 | — |
| SC TO-T/A | Filing | Jul 6, 2022 | — |
| SC 14D9/A | Filing | Jun 28, 2022 | — |
| SC TO-T/A | Filing | Jun 23, 2022 | — |
| SC 14D9 | Filing | Jun 13, 2022 | — |
| SC TO-T | Filing | Jun 6, 2022 | — |
| SC TO-C | Filing | May 31, 2022 | — |
| SC14D9C | Filing | May 31, 2022 | — |
| POSASR | Filing | Mar 23, 2022 | — |
| SC TO-I/A | Filing | Oct 1, 2021 | — |
| SC TO-I/A | Filing | Aug 30, 2021 | — |
| SC TO-I | Filing | Aug 26, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 19, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 22, 2021 | — |
| D | Filing | Aug 14, 2020 | — |
| EFFECT | Filing | May 5, 2020 | — |
| PRER14A | Preliminary revised proxy soliciting materials | Apr 22, 2020 | — |
| SEC STAFF LETTER | Filing | Mar 5, 2020 | — |
| POSASR | Filing | Feb 24, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 4, 2020 | — |
| CT ORDER | Filing | Apr 10, 2019 | — |
| CT ORDER | Filing | Dec 12, 2018 | — |
| CT ORDER | Filing | Aug 21, 2018 | — |
| CERTNAS | Auto-generated paper document | Oct 6, 2017 | — |
| 8-A12B | Registration of certain classes of securities | Oct 6, 2017 | — |
| 25 | Notification filed by issuer to voluntary withdraw class of securities | Oct 6, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2017 | — |
| CORRESP | Letter to the SEC | Jan 31, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2017 | — |
| CORRESP | Letter to the SEC | Dec 29, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2016 | — |
| EFFECT | Filing | Nov 17, 2015 | — |
| CORRESP | Letter to the SEC | Nov 13, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2015 | — |
| CORRESP | Letter to the SEC | Apr 24, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2015 | — |
| EFFECT | Filing | Jan 29, 2015 | — |
| CORRESP | Letter to the SEC | Jan 27, 2015 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2015 | — |
| CORRESP | Letter to the SEC | Jan 8, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2014 | — |
| UPLOAD | Letter from the SEC | Dec 24, 2014 | — |
| EFFECT | Filing | Feb 3, 2014 | — |
| EFFECT | Filing | Dec 12, 2013 | — |
| EFFECT | Filing | Oct 15, 2013 | — |
| CERTNYS | Auto-generated paper document | Apr 22, 2013 | — |
| 8-A12B | Current report | Apr 22, 2013 | — |
| EFFECT | Filing | Feb 5, 2013 | — |
| EFFECT | Filing | Dec 12, 2012 | — |
| D | Filing | Oct 10, 2012 | — |
| CT ORDER | Filing | Aug 28, 2012 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2012 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2012 | — |
| CT ORDER | Filing | Feb 6, 2012 | — |
| CORRESP | Letter to the SEC | Feb 3, 2012 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2012 | — |
| CORRESP | Letter to the SEC | Dec 8, 2011 | — |
| CORRESP | Letter to the SEC | Nov 22, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2011 | — |
| CORRESP | Letter to the SEC | Aug 30, 2011 | — |
| PRER14C | Preliminary revised information statements | Aug 30, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2011 | — |
| NT 10-Q | Notification of late filing | May 16, 2011 | Mar 31, 2011 |
| NT 10-K | Notification of late filing | Mar 31, 2011 | Dec 31, 2010 |
| PRER14C | Revised preliminary schedule 14c | Jun 17, 2010 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2009 | — |
| UPLOAD | Letter from the SEC | Oct 1, 2009 | — |
| PRER14C | Preliminary revised schedule 14c | Aug 24, 2009 | — |
Showing 79 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TXMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 25743
- Former names
- AMHN, Inc. (until Sep 14, 2011); CROFF ENTERPRISES INC (until Sep 4, 2009); CROFF OIL CO (until Apr 1, 1997)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.